{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:17:21Z","timestamp":1787001441906,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1023\/a:1024751420515","type":"journal-article","created":{"date-parts":[[2003,9,15]],"date-time":"2003-09-15T17:50:13Z","timestamp":1063648213000},"page":"1487-1494","source":"Crossref","is-referenced-by-count":3,"title":["Increased Reflux Symptoms After Calcium Carbonate Supplementation and Successful Anti-Helicobacter pylori Treatment"],"prefix":"10.1007","volume":"48","author":[{"given":"Lori A.","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelayo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Fontham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Priest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"471038_CR1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1572-0241.1999.1123_a.x","volume":"94","author":"KR De Vault","year":"1999","unstructured":"De Vault KR, Castell DO: The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for diagnosis and treatment of gastroesophageal reflux disease. Practice guidelines. Am J Gastroenterol 94:1434\u20131442, 1999","journal-title":"Am J Gastroenterol"},{"key":"471038_CR2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke","year":"1997","unstructured":"Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448\u20131456, 1997","journal-title":"Gastroenterology"},{"key":"471038_CR3","first-page":"5","volume":"211","author":"H. Petersen","year":"1995","unstructured":"Petersen H. Prevalence of gastroesophageal reflux disease: Scand J Gastroenterol Suppl 211:5\u20136, 1995","journal-title":"Prevalence of gastroesophageal reflux disease: Scand J Gastroenterol Suppl"},{"key":"471038_CR4","unstructured":"A Gallup survey on heartburn across America. Princeton, New Jersey, The Gallup Organization, Inc., 1988"},{"key":"471038_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF01071906","volume":"21","author":"OT Nebel","year":"1976","unstructured":"Nebel OT, Fornes MF, Castell DO: Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 21:953\u2013956, 1976","journal-title":"Am J Dig Dis"},{"key":"471038_CR6","first-page":"56","volume":"146","author":"L Jaroff","year":"1995","unstructured":"Jaroff L: Fire in the belly, money in the bank. TIME Magazine 146:56\u201358, 1995","journal-title":"TIME Magazine"},{"key":"471038_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0889-8553(05)70138-2","volume":"29","author":"KE McColl","year":"2000","unstructured":"McColl KE, el-Omar E, Gillen D: Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Gastroenterol Clin North Am 29:687\u2013703, 2000","journal-title":"Gastroenterol Clin North Am"},{"key":"471038_CR8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0016-5085(91)90724-Y","volume":"101","author":"M Goldschmiedt","year":"1991","unstructured":"Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M: Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology101:977\u2013990, 1991","journal-title":"Gastroenterology"},{"key":"471038_CR9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","volume":"110","author":"J Labenz","year":"1996","unstructured":"Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, Borsch G, Blum AL: Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterol 110:725\u2013732, 1996","journal-title":"Gastroenterol"},{"key":"471038_CR10","first-page":"576","volume":"92","author":"J Labenz","year":"1997","unstructured":"Labenz J, Tillenburg B, Peitz U, Borsch G, Idstrom JP, Verdu E, Stolte M, Blum AL: Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 92:576\u2013581, 1997","journal-title":"Am J Gastroenterol"},{"key":"471038_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.2000.00758.x","volume":"14","author":"H Hamada","year":"2000","unstructured":"Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara M, Sumii K, Kajiyama G, Kawanishi M: High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729\u2013735, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"471038_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1523-5378.2000.00003.x","volume":"5","author":"K Haruma","year":"2000","unstructured":"Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, Kajiyama G, Kawanishi M: Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 5:24\u201329, 2000","journal-title":"Helicobacter"},{"key":"471038_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1523-5378.1998.08001.x","volume":"3","author":"RV Varanasi","year":"1998","unstructured":"Varanasi RV, Fantry GT, Wilson KT: Decreased prevalence of Helicobacterpylori infection in gastroesophageal reflux disease. Helicobacter3:188\u2013194, 1998","journal-title":"Helicobacter"},{"key":"471038_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1018841222856","volume":"42","author":"BFM Werdmuller","year":"1997","unstructured":"Werdmuller BFM, Loffeld RJLF: Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 42:103\u2013105, 1997","journal-title":"Dig Dis Sci"},{"key":"471038_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/pgmj.71.837.413","volume":"71","author":"PS Phull","year":"1995","unstructured":"Phull PS, Ryder SD Halliday D, Price AB, Levi AJ, Jacyna MR: The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease-a community-based study. Postgrad Med J 71:413\u2013418, 1995","journal-title":"Postgrad Med J"},{"issue":"suppl1","key":"471038_CR16","first-page":"12\/9","volume":"47","author":"MP Dore","year":"2000","unstructured":"Dore MP, Leandro G, Idda M, Carta M, Bilotta M, Realdi G: Cure Helicobacter pylori may cure symptomatic gastroesophageal reflux disease. Gut 47(suppl 1):12\/9, 2000","journal-title":"Gut"},{"key":"471038_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1523-5378.2000.00031.x","volume":"5","author":"R Befrits","year":"2000","unstructured":"Befrits R, Sjostedt S, Odman B, Sorngard H, Lindbery G: Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 5:202\u2013205, 2000","journal-title":"Helicobacter"},{"key":"471038_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2036.2000.00677.x","volume":"14","author":"N Vakil","year":"2000","unstructured":"Vakil N, Hahn B, McSorley D: Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori. Aliment Pharmacol Ther 14:45\u201351, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"471038_CR19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0016-5085(97)70024-6","volume":"112","author":"J Labenz","year":"1997","unstructured":"Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G:Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterol 112:1442\u20131447, 1997","journal-title":"Gastroenterol"},{"key":"471038_CR20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2000.01929.x","volume":"95","author":"CA Fallone","year":"2000","unstructured":"Fallone CA, Barkun AN, Friedman G, Mayrand S, Loo V, Baech R, Best L, Joseph L: Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 95:914\u2013920, 2000","journal-title":"Am J Gastroenterol"},{"key":"471038_CR21","doi-asserted-by":"crossref","first-page":"A212","DOI":"10.1016\/S0016-5085(98)80862-7","volume":"114","author":"P Malfertheiner","year":"1998","unstructured":"Malfertheiner P, van Zanten SV, Dent J, Bayerdorffer E, Lind T, O'Morain C, Spiller RC Unge P, Zeijlon L: Does cure of Helicobacter pylori infection induce heartburn? Gastroenterol 114:A212(G0870), 1998","journal-title":"Gastroenterol"},{"key":"471038_CR22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1365-2036.2001.00998.x","volume":"15","author":"LA Fischbach","year":"2001","unstructured":"Fischbach LA, Correa P, Ramirez H, Realpe JL, Collazos T, Ruiz B, Bravo LE, Bravo JC, Casabon AL, Schmidt BA: Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer. Aliment Pharmacol Ther 15:831\u2013841, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"471038_CR23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/57.5.1027","volume":"57","author":"P Correa","year":"1976","unstructured":"Correa P, Cuello C, Duque E, Bubano LC, Garcia FT, Bolanos O, Brown C, Haenszel W: Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 57:1027\u20131035, 1976","journal-title":"J Natl Cancer Inst"},{"key":"471038_CR24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I","volume":"66","author":"P Correa","year":"1990","unstructured":"Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, Taylor N, MacKinley D, de Lima E, Portilla H: Helicobacter pylori and gastric carcinoma. Cancer 66:2569\u20132574, 1990","journal-title":"Cancer"},{"key":"471038_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0895-4356(93)90075-C","volume":"46","author":"SJ Veldhuyzen van Zanten","year":"1993","unstructured":"Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, Goldie J, Goodacre RT, Riddell RH, Hunt RH: Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 46:273\u2013279, 1993","journal-title":"J Clin Epidemiol"},{"key":"471038_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ajcp\/105.1.96","volume":"105","author":"B Ruiz","year":"1996","unstructured":"Ruiz B, Correa P, Fontham ET, Ramakrishnan T: Antral atrophy, Helicobacter pylori colonization, and gastric pH. Am J Clin Pathol.105:96\u2013101, 1996","journal-title":"Am J Clin Pathol."},{"key":"471038_CR27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01297133","volume":"36","author":"M Feldman","year":"1991","unstructured":"Feldman M, Barnett C: Fasting gastric pH and its relationship to true hypochlorhydria in humans. Dig Dis Sci 36:866\u2013869, 1991","journal-title":"Dig Dis Sci"},{"key":"471038_CR28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"M Dixon","year":"1996","unstructured":"Dixon M, Genta R, Yardley J, Correa P: Classification and grading of gastritis. The updated Sydney system. AmJ Surg Pathol 20:1161\u20131181, 1996","journal-title":"AmJ Surg Pathol"},{"key":"471038_CR29","first-page":"169","volume-title":"Epidemiology: Principles and Methods","author":"B MacMahon","year":"1996","unstructured":"MacMahon B, Trichopoulos D: Epidemiology: Principles and Methods. 2nd edn. New York, Little Brown and Company, 1996, pp 169\u2013170","edition":"2nd edn"},{"key":"471038_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00048678909062134","volume":"23","author":"G. Andrews","year":"1989","unstructured":"Andrews G. Evaluating treatment effectiveness. Aust NZ J Psychiatry 23:181\u2013186, 1989","journal-title":"Aust NZ J Psychiatry"},{"key":"471038_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1440-1746.2000.02131.x","volume":"15","author":"K Haruma","year":"2000","unstructured":"Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Inoue M, Kishimoto S, Kayiyama G, Miyoshi A: Effect of age and Helicobacter pylori infection on gastric acid secretion.J Gastroenterol Hepatol 15:277\u2013280, 2000","journal-title":"J Gastroenterol Hepatol"},{"key":"471038_CR32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI110818","volume":"71","author":"M Feldman","year":"1983","unstructured":"Feldman M, Richardson CT, Walsh JH: Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings. J Clin Invest 71:715\u2013720, 1983","journal-title":"J Clin Invest"},{"key":"471038_CR33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/000348940111000216","volume":"110","author":"CF Smit","year":"2002","unstructured":"Smit CF, Copper MP, van Leeuwen JA, Schoots IG, Stanojcic LD: Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux. Ann Otol Rhinol Laryngol 110:190\u2013193, 2002","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"471038_CR34","first-page":"625","volume":"8","author":"DO Castell","year":"1996","unstructured":"Castell DO: Obesity and gastroesophageal reflux: Is there a relationship? Eur J Gastroenterol Hepatol 8:625\u2013626, 1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"471038_CR35","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.1987.03400150069031","volume":"258","author":"GC Vitale","year":"1987","unstructured":"Vitale GC, Cheadle WG,Patel B, Sadek SA, Michel ME, Cushieri A: The effect of alcohol on nocturnal gastroesophageal reflux. JAMA258:2077\u20132079, 1987","journal-title":"JAMA"},{"key":"471038_CR36","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1023\/A:1013010616496","volume":"18","author":"J Kotzan","year":"2001","unstructured":"Kotzan J, Wade W, Yu HH: Assessing NSAID prescription use as a predisposing factor for gatroesophageal reflux disease in a Medicaid population. Pharm Res 18:1367\u20131372, 2001","journal-title":"Pharm Res"},{"key":"471038_CR37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/BF02091532","volume":"41","author":"K Iwakiri","year":"1996","unstructured":"Iwakiri K, Kobayashi M, Kotoyori M, Yamada H, Sugiura T, Nakagawa Y: Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci. 41:926\u2013930, 1996","journal-title":"Dig Dis Sci."},{"key":"471038_CR38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2036.1997.00161.x","volume":"11","author":"C Pehl","year":"1997","unstructured":"Pehl C, Pfeiffer A, Wendl B, Kaess H: The effect of decaffeination of coffee on gastroesophageal reflux in patients with reflux disease.Aliment Pharmacol Ther 11:483\u2013486, 1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"2\u20133","key":"471038_CR39","first-page":"169","volume":"72","author":"M. Robinson","year":"1999","unstructured":"Robinson M. Drugs, bugs and esophageal pH profiles. Yale J Biol Med 72(2\u20133):169\u2013172, 1999","journal-title":"Yale J Biol Med"},{"key":"471038_CR40","first-page":"708","volume-title":"Gastrointestinal Disease","author":"WL Peterson","year":"1983","unstructured":"Peterson WL, Richardson, CT: Pharmacology and side effects of drugs used to treat peptic ulcer. In Gastrointestinal Disease, 3rd edn. MH Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders, 1983, pp 708\u2013725","edition":"3rd edn"},{"key":"471038_CR41","volume-title":"Modern Epidemiology","author":"KJ Rothman","year":"1998","unstructured":"Rothman KJ, Greenland S: Modern Epidemiology, 2nd ed. Philadelphea, Lippincott Raven, 1998","edition":"2nd ed"},{"key":"471038_CR42","doi-asserted-by":"crossref","first-page":"A239","DOI":"10.1016\/S0016-5085(99)70118-6","volume":"116","author":"R Loffeld","year":"1999","unstructured":"Loffeld R, Werdmuller B, Kusters JG, Perez-Perez GI, Blaser MJ, Kuipers EJ: Cag-A H. pylori (HP) infection protects against GERD. Gastroenterology 116:A239 (G1038), 1999","journal-title":"Gastroenterology"},{"key":"471038_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gut.40.1.9","volume":"40","author":"M Newton","year":"1997","unstructured":"Newton M, Bryan R, Burnham WR, Kamm MA: Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 40:9\u201313, 1997","journal-title":"Gut"},{"key":"471038_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0016-5085(98)70364-6","volume":"115","author":"JJ Vicari","year":"1998","unstructured":"Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, Perez-Perez GI, Halter SA, Rice TW, Blaser MJ, Richter JE:The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology115:50\u201357, 1998","journal-title":"Gastroenterology"},{"key":"471038_CR45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1989.00390060097020","volume":"149","author":"EH Cheng","year":"1989","unstructured":"Cheng EH, Bermanski P, Sivlersmith M, Valenstein P, Kawanishi H: Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med 149:1373\u20131375, 1989","journal-title":"Arch Intern Med"},{"key":"471038_CR46","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.2001.01017.x","volume":"15","author":"GJB Hurnekamp","year":"2001","unstructured":"Hurnekamp GJB, Grundmeijer HGLM, van der Ende A, Tytgat GN, Assendeift WJ, Van der Hulst RW: Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study. Aliment Pharmacol Ther 15:1047\u20131054, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"471038_CR47","doi-asserted-by":"crossref","first-page":"A306","DOI":"10.1016\/S0016-5085(98)81240-7","volume":"114","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Janssens J, Lauitsen K, Racz I, Bolling-Sternevald E, Havu N, Junghard O, Sjoogren G: No increase in reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterol 114:A306(G1250), 1998","journal-title":"Gastroenterol"},{"key":"471038_CR48","first-page":"G1159","volume":"277","author":"M Feldman","year":"1999","unstructured":"Feldman M, Cryer B, Sammer D, Lee E, Spechler S: Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesopahgeal acid reflux. Am J Physiol 277:G1159\u2013G1164, 1999","journal-title":"Am J Physiol"},{"key":"471038_CR49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2036.2002.01153.x","volume":"16","author":"DP Hirsch","year":"2002","unstructured":"Hirsch DP, Tytgat GN, Boeckxstaens GE: Transient lower oesophageal sphincter relaxations-a pharmacological target for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 16:17\u201326, 2002","journal-title":"Aliment Pharmacol Ther"},{"key":"471038_CR50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1052-3359(25)00589-7","volume":"11","author":"G Tougas","year":"2001","unstructured":"Tougas G, Banemai M: Gastroesophageal reflux disease pathophysiology.Chest Surg Clin North Am. 11:485\u2013494, 2001","journal-title":"Chest Surg Clin North Am."},{"key":"471038_CR51","first-page":"S4","volume":"50","author":"EM Bozymski","year":"1993","unstructured":"Bozymski EM: Pathophysiology and diagnosis of gastroesophageal reflux disease. Am J Hosp Pharm 50:S4\u2013S6, 1993","journal-title":"Am J Hosp Pharm"},{"key":"471038_CR52","first-page":"130","volume":"3","author":"SJ Sontag","year":"1992","unstructured":"Sontag SJ: Gastroesophageal reflux disease and its consequences. J Assoc Acad Minor Physicians 3:130\u2013136, 1992","journal-title":"J Assoc Acad Minor Physicians"},{"key":"471038_CR53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1052-3359(25)00588-5","volume":"11","author":"WG Paterson","year":"2001","unstructured":"Paterson WG: The normal antireflux mechanism. Chest Surg Clin North Am 11:473\u2013483, 2001","journal-title":"Chest Surg Clin North Am"},{"key":"471038_CR54","first-page":"471","volume":"32","author":"J Estevao-Costa","year":"2001","unstructured":"Estevao-Costa J, Campos M, Dias JA, Tridade E, Medina AM, Carvalho JL: Delayed gastric emptying and gastroesophageal reflux: a pathophysicologic relationship. J Pediatr Gastroenterol Nutr 32: 471\u2013474, 2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"471038_CR55","unstructured":"GlaxoSmithKline Consumer Healthcare. Pittsburgh, Pennsylvania, USA. TUMS website in the United States at http:\/\/www.tums.com\/ab history.asp1494"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024751420515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1024751420515\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1024751420515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:57:30Z","timestamp":1753761450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1024751420515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["471038"],"URL":"https:\/\/doi.org\/10.1023\/a:1024751420515","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}